Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
GLP-1 drugs covered under the Bridge include tirzepatide (Zepbound, Foundayo) and semaglutide (Wegovy), prescribed specifically for weight loss
[3] [11] In its press release, Lilly noted that the subjects' weight loss had not yet plateaued at the time the trial concluded, and suggested that this indicated that greater weight reduction would ultimately be achieved with extended therapy
( PMID:39355484;PMCID:PMC11444311 )
Citraro R, Leo A, De Caro C, Nesci V, Gallo Cantafio ME, Amodio N, et al
Athletes are not good candidates if: They are chronically under-fueling They have a history of an eating disorder or disordered eating If their nutrition, recovery, and other key lifestyle habits aren't yet well established Athletes may benefit, alongside comprehensive nutrition and medical care, if: They're experiencing overweight/obesity or metabolic disease Have significant inflammation or other medical conditions Have experienced certain peri/post-menopausal changes Even if you're a good candidate for GLP-1 meds, there are still potential risks
Customized Wellness or Aesthetic Plan Based on your evaluation, we develop a personalized plan that may include GHK-Cu alongside other regenerative or aesthetic therapies
